1 |
Vancheri C, Morini E, Prandi FR, Barillà F, Romeo F, Novelli G, Amati F. Downregulation of Circulating Hsa-miR-200c-3p Correlates with Dyslipidemia in Patients with Stable Coronary Artery Disease. Int J Mol Sci 2023;24. [PMID: 36674633 DOI: 10.3390/ijms24021112] [Reference Citation Analysis]
|
2 |
Esawy MM, Saleh Al-Sowayan N, Mobasher MA, Abd-Elhameed A, Abd Elbaser ES, Baioumy SA, Shabana MA. H19 and TUG1 lncRNAs as Novel Biomarkers for Irritable Bowel Syndrome in Diabetic Patients. Biomedicines 2022;10. [PMID: 36428545 DOI: 10.3390/biomedicines10112978] [Reference Citation Analysis]
|
3 |
Wu J, Chu E, Paul B, Kang Y. Mechanistic Studies and a Retrospective Cohort Study: The Interaction between PPAR Agonists and Immunomodulatory Agents in Multiple Myeloma. Cancers (Basel) 2022;14. [PMID: 36358696 DOI: 10.3390/cancers14215272] [Reference Citation Analysis]
|
4 |
Zafar S, Faisal S, Jan H, Ullah R, Rizwan M, Abdullah, Alotaibi A, Bibi N, Rashid AU, Khattak A. Development of Iron Nanoparticles (FeNPs) Using Biomass of Enterobacter: Its Characterization, Antimicrobial, Anti-Alzheimer's, and Enzyme Inhibition Potential. Micromachines (Basel) 2022;13:1259. [PMID: 36014181 DOI: 10.3390/mi13081259] [Reference Citation Analysis]
|